Aurobindo Pharma U.S.A., Inc. 401(K) Plan — Form 5500 plan (Aurobindo Pharma U.S.A., Inc.)

Plain-English plan summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Aurobindo Pharma U.S.A., Inc. 401(K) Plan is a benefit plan reported by Aurobindo Pharma U.S.A., Inc. under EIN 20-0962874 and plan number 001. The latest loaded filing year is 2023. The filing reports 785 participants and $43,087,557 in end-of-year plan assets, where available in the loaded dataset.

Key reported metrics

Plan sponsor
Aurobindo Pharma U.S.A., Inc.
EIN
20-0962874
Plan number
001
Plan type
2
Location
East Windsor, NJ
Latest filing year
2023
Participants
785
End-of-year plan assets
$43,087,557

Form 5500 filing history

Filings loaded for this plan
Filing yearParticipantsSchedulesFiling
2023785H, C20241010093038NAL0020758609001

Reported financial statement (2023 · Schedule H)

Net assets

Total assets (EOY)
$43,087,557
Total liabilities (EOY)
$0
Net assets (EOY)
$43,087,557
Net assets (BOY)
$34,796,188

Income & contributions

Employer contributions
$1,458,739
Participant contributions
$4,145,770
Total contributions
$5,875,631
Total income / additions
$12,464,639

Expenses & distributions

Benefits paid
$4,049,114
Administrative expenses
$124,156
Total expenses
$4,173,270
Net increase / (decrease)
$8,291,369

Service provider compensation (Schedule C)

Reported service provider compensation
ProviderServiceDirect comp.Indirect comp.Year
Global Retirement Partners LLCADVISOR$92,399not reported in the loaded dataset2023
Withumsmith+BrownACCOUNTANT/AUDITOR$29,422not reported in the loaded dataset2023
Fidelity Investments InstitutionalRECORDKEEPER-$96$02023

Related Form 5500 pages